Equitable Trust Co. Invests $680,000 in Colgate-Palmolive Company $CL

Equitable Trust Co. bought a new position in shares of Colgate-Palmolive Company (NYSE:CL) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 7,984 shares of the company’s stock, valued at approximately $680,000.

Several other large investors have also recently bought and sold shares of the stock. Kemnay Advisory Services Inc. acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $25,000. CBIZ Investment Advisory Services LLC lifted its holdings in Colgate-Palmolive by 86.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after purchasing an additional 150 shares during the last quarter. TD Capital Management LLC boosted its stake in Colgate-Palmolive by 61.4% in the 4th quarter. TD Capital Management LLC now owns 326 shares of the company’s stock valued at $26,000 after purchasing an additional 124 shares during the period. Triumph Capital Management boosted its stake in Colgate-Palmolive by 62.9% in the 4th quarter. Triumph Capital Management now owns 329 shares of the company’s stock valued at $26,000 after purchasing an additional 127 shares during the period. Finally, Jessup Wealth Management Inc acquired a new position in Colgate-Palmolive in the 4th quarter valued at $26,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock traded up $1.30 during trading hours on Friday, reaching $92.31. 4,257,117 shares of the stock were exchanged, compared to its average volume of 4,923,956. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a market cap of $73.86 billion, a P/E ratio of 35.92, a price-to-earnings-growth ratio of 4.86 and a beta of 0.33. The stock has a 50 day moving average of $89.91 and a two-hundred day moving average of $88.10.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. During the same period in the previous year, the company earned $0.91 EPS. The business’s revenue for the quarter was up 8.4% compared to the same quarter last year. Equities analysts expect that Colgate-Palmolive Company will post 3.81 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is presently 82.49%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CL. UBS Group boosted their target price on shares of Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Rothschild & Co Redburn set a $100.00 price objective on shares of Colgate-Palmolive and gave the stock a “buy” rating in a research note on Tuesday, April 21st. Sanford C. Bernstein assumed coverage on shares of Colgate-Palmolive in a research report on Thursday, June 11th. They set a “market perform” rating and a $96.00 target price on the stock. Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday, March 29th. Finally, The Goldman Sachs Group reiterated a “buy” rating on shares of Colgate-Palmolive in a research note on Friday, May 1st. Twelve research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $96.29.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.